![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Xu Wen Zhang Tingting Wang Zhi Liu Tao Liu Yanping Cao Zhihong Sui Zhongguo
Publisher: Govi-Verlag
ISSN: 0031-7144
Source: Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.12, 2013-12, pp. : 974-976
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hedenmalm Karin Lindh Jonatan Säwe Juliette Rane Anders
European Journal of Clinical Pharmacology, Vol. 60, Iss. 5, 2004-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bupropion [amfebutamone] sustained-release (SR) is a potent inhibitor of cytochrome P450 (CYP)2D6
Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. :